C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 451/06 (2006.01) A61K 31/46 (2006.01) A61K 31/538 (2006.01) A61K 31/55 (2006.01) A61P 37/02 (2006.01) C07D 451/04 (2006.01) C07D 451/14 (2006.01)
Patent
CA 2492110
A compound of the formula (I) wherein a, b, cR1, R2, R3, R4, R5, R6, Q, W, Y, and Z are defined as above, useful as potent and selective inhibitors of MIP- 1.alpha.(CCL3) binding to its receptor CCR1 found on inflammatory and immunomodulatory cells (preferably leukocytes and lymphocytes).
L'invention concerne un composé représenté par la formule (I) dans laquelle a, b, c, R?1¿, R?2¿, R?3¿, R?4¿, R?5¿, R?6¿, Q, W, Y, et Z sont tels que définis dans le descriptif. Ce composé est indiqué en tant qu'inhibiteur puissant et sélectif de la liaison de MIP-1.alpha.(CCL3) avec son récepteur CCR1 présent sur les cellules inflammatoires et immunomodulatrices (de préférence leucocytes et lymphocytes).
Blumberg Laura Cook
Brown Matthew Frank
Hayward Matthew Merrill
Poss Christopher Stanley
Pfizer Products Inc.
Sim & Mcburney
LandOfFree
Bicyclic piperidine derivatives as antagonists of the ccr1... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bicyclic piperidine derivatives as antagonists of the ccr1..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicyclic piperidine derivatives as antagonists of the ccr1... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1497359